La presentazione è in caricamento. Aspetta per favore

La presentazione è in caricamento. Aspetta per favore

Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia by Andrea Pession, Riccardo Masetti,

PubblicatoSandra Gentili Modificato 9 anni fa

Presentazioni simili

Presentazione sul tema: "Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia by Andrea Pession, Riccardo Masetti,"— Transcript della presentazione:

1 Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia by Andrea Pession, Riccardo Masetti, Carmelo Rizzari, Maria Caterina Putti, Fiorina Casale, Franca Fagioli, Matteo Luciani, Luca Lo Nigro, Giuseppe Menna, Concetta Micalizzi, Nicola Santoro, Anna Maria Testi, Marco Zecca, Andrea Biondi, Martina Pigazzi, Sergio Rutella, Roberto Rondelli, Giuseppe Basso, and Franco Locatelli Blood Volume 122(2):170-178 July 11, 2013 ©2013 by American Society of Hematology

2 Schematic representation of the induction and consolidation courses employed for treating patients enrolled in the AIEOP AML 2002/01 trial. Andrea Pession et al. Blood 2013;122:170-178 ©2013 by American Society of Hematology

3 Flowchart of patients enrolled in the 2000/01 AML protocol. Andrea Pession et al. Blood 2013;122:170-178 ©2013 by American Society of Hematology

4 Eight-year probability of OS and EFS for the whole cohort of 482 children enrolled in the AIEOP AML 2002/01 trial. Andrea Pession et al. Blood 2013;122:170-178 ©2013 by American Society of Hematology

5 Eight-year probability of OS, EFS, DFS, and CI of relapse for SR and HR children enrolled in the AIEOP AML 2002/01 trial. Andrea Pession et al. Blood 2013;122:170-178 ©2013 by American Society of Hematology

Scaricare ppt "Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia by Andrea Pession, Riccardo Masetti,"

Presentazioni simili

Il Registro Ospedaliero della Associazione Italiana

Il Registro Ospedaliero della Associazione Italiana
Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the.

Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the.
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation by Mauro Di Ianni, Franca Falzetti, Alessandra Carotti, Adelmo.

Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation by Mauro Di Ianni, Franca Falzetti, Alessandra Carotti, Adelmo.
Genome Search in Celiac Disease Luigi Greco, Gino Corazza, Marie-Claude Babron, Fabienne Clot, Marie-Claude Fulchignoni-Lataud, Selvaggia Percopo, Patrizia.

Genome Search in Celiac Disease Luigi Greco, Gino Corazza, Marie-Claude Babron, Fabienne Clot, Marie-Claude Fulchignoni-Lataud, Selvaggia Percopo, Patrizia.
Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study by Sara Bringhen, Maria.

Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study by Sara Bringhen, Maria.
Efficacy and safety of once-weekly bortezomib in multiple myeloma patients by Sara Bringhen, Alessandra Larocca, Davide Rossi, Maide Cavalli, Mariella.

Efficacy and safety of once-weekly bortezomib in multiple myeloma patients by Sara Bringhen, Alessandra Larocca, Davide Rossi, Maide Cavalli, Mariella.
Additional chromosomal abnormalities in Philadelphia- positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party.

Additional chromosomal abnormalities in Philadelphia- positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party.
Identification of a New Locus for Medullary Cystic Disease, on Chromosome 16p12 Francesco Scolari, Daniela Puzzer, Antonio Amoroso, Gianluca Caridi, Gian.

Identification of a New Locus for Medullary Cystic Disease, on Chromosome 16p12 Francesco Scolari, Daniela Puzzer, Antonio Amoroso, Gianluca Caridi, Gian.
Deferiprone Versus Deferoxamine in Thalassemia Intermedia: Results from 5-Year Long-Term Italian Multi- Center Randomized Clinical Trial by Angela Vitrano,

Deferiprone Versus Deferoxamine in Thalassemia Intermedia: Results from 5-Year Long-Term Italian Multi- Center Randomized Clinical Trial by Angela Vitrano,
Minimal Emergence of Darunavir Resistance at Treatment Failure: Are Interpretation Algorithms Adequate? Gaetana Sterrantino* 1, Mauro Zaccarelli 2, Maurizio.

Minimal Emergence of Darunavir Resistance at Treatment Failure: Are Interpretation Algorithms Adequate? Gaetana Sterrantino* 1, Mauro Zaccarelli 2, Maurizio.
PET/CT Is a Useful Tool For Both Refining The Definition Of Complete Response (CR) In Multiple Myeloma (MM) and Detecting Otherwise Unrevealed Progression.

PET/CT Is a Useful Tool For Both Refining The Definition Of Complete Response (CR) In Multiple Myeloma (MM) and Detecting Otherwise Unrevealed Progression.
Randomized Trial of Busulfan with Cyclophosphamide Versus Busulfan with Fludarabine As Preparative Regimen to Allogeneic Hematopoietic Stem Cell Transplantation.

Randomized Trial of Busulfan with Cyclophosphamide Versus Busulfan with Fludarabine As Preparative Regimen to Allogeneic Hematopoietic Stem Cell Transplantation.
Incidence and Outcome of Invasive Fungal Diseases after Allogeneic Stem Cell Transplantation: A Prospective Study of the Gruppo Italiano Trapianto Midollo.

Incidence and Outcome of Invasive Fungal Diseases after Allogeneic Stem Cell Transplantation: A Prospective Study of the Gruppo Italiano Trapianto Midollo.
Long-Term Outcome to First-Line Imatinib according to 2013 European LeukemiaNet Response Criteria: a GIMEMA CML WP Analysis by Fausto Castagnetti, Gabriele.

Long-Term Outcome to First-Line Imatinib according to 2013 European LeukemiaNet Response Criteria: a GIMEMA CML WP Analysis by Fausto Castagnetti, Gabriele.
Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia by Luca Malcovati, Elli Papaemmanuil, Ilaria Ambaglio,

Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia by Luca Malcovati, Elli Papaemmanuil, Ilaria Ambaglio,
XXIX^ Riunione Nazionale MITO – Sessione Data Manager 21 Giugno 2017

XXIX^ Riunione Nazionale MITO – Sessione Data Manager 21 Giugno 2017
Venoarterial Extracorporeal Membrane Oxygenation for Acute Fulminant Myocarditis in Adult Patients: A 5-Year Multi-Institutional Experience  Roberto Lorusso,

Venoarterial Extracorporeal Membrane Oxygenation for Acute Fulminant Myocarditis in Adult Patients: A 5-Year Multi-Institutional Experience  Roberto Lorusso,
Long-term clinical evaluation in patients with Parkinson's disease and early autonomic involvement  Claudio Lucetti, Gianna Gambaccini, Paolo Del Dotto,

Long-term clinical evaluation in patients with Parkinson's disease and early autonomic involvement  Claudio Lucetti, Gianna Gambaccini, Paolo Del Dotto,
The prognostic value of biological markers in paediatric Hodgkin lymphoma  Piero Farruggia, Giuseppe Puccio, Alessandra Sala, Alessandra Todesco, Salvatore.

The prognostic value of biological markers in paediatric Hodgkin lymphoma  Piero Farruggia, Giuseppe Puccio, Alessandra Sala, Alessandra Todesco, Salvatore.
How to manage children who have come into contact with patients affected by tuberculosis  Laura Lancella, Andrea Lo Vecchio, Elena Chiappini, Marina Tadolini,

How to manage children who have come into contact with patients affected by tuberculosis  Laura Lancella, Andrea Lo Vecchio, Elena Chiappini, Marina Tadolini,

Presentazioni simili

Annunci Google